SORIN GROUP is a global medical device company and a leader in the treatment of cardiovascular diseases.
The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

With over 3,700 employees worldwide, the company focuses on three major therapeutic areas:
• cardiopulmonary bypass
• cardiac rhythm management (CRM)
• heart valve repair and replacement

Each year, over one million patients are treated with SORIN GROUP devices in more than 80 countries.
We serve over 5,000 hospitals worldwide.
Headquartered in Milan, Italy, SORIN GROUP is listed on the Milan Stock Exchange.

Supporting the aspirations for tomorrow

EXPERTS IN CARDIOVASCULAR DISEASES
SORIN GROUP’s success is built around its cardiovascular products and related therapeutic services. After divesting its non-core businesses, SORIN GROUP is now focusing on cardiovascular activities: Cardiopulmonary, Heart Valves and Cardiac Rhythm Management. Through continued expansion and development, SORIN GROUP has established itself as a market leader within cardiovascular device technology. Bolstered by a strong financial trajectory and the drive to continuously improve patient care, SORIN GROUP has ambitious plans for future expansion. SORIN GROUP is committed to focusing on long-term growth in the cardiovascular market by leveraging on R&D innovation, geographical expansion and potential acquisitions.

EXCELLENCE IN QUALITY AND ETHICS
SORIN GROUP’s devices are built to save lives. Across the globe we strive for the highest levels of performance and quality while maintaining rigorous standards of ethics in our business practices.

Saving the lives of disadvantaged children with heart diseases

Since January 2010, Sorin Group has established a long-term partnership with Bambini Cardiopatici Nel Mondo, a charitable organization that provides pediatric cardiac surgery in developing countries.
 
The agreement provides for regular charitable donations in support of the organization’s humanitarian activities. Direct financial contributions will amount to no less than EUR 600,000 over three years, while Sorin will also donate its life-saving medical devices to the organization.
 
Sorin employees are also participating actively as volunteers in the work of Bambini Cardiopatici nel Mondo. To learn more about the missions in which Sorin employees participated, click here
 
To date Bambini Cardiopaticci Nel Mondo and its 150 active volunteers have performed over 1,000 operations in 23 countries.
 
To learn more about Bambini Cardiopatici, click here.